Further information Jens Juul Holst, MD, DMSc, professor at the Department of Biomedical Sciences and the Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Sciences, University of Copenhagen, [email protected], +45 1875 7528 Christian Mostrup, Head of Press, Novo Nordisk Foundation, [email protected], +45 3067 4805
Ruscoe JE, Rosario LA, Wang T, Gat L, Arifoglu P, Wolf CR et al
NICE guidance (NG28) on type 2 diabetes management recognises GLP-1 receptor agonists as effective second- or third-line therapies, particularly for patients with obesity or those requiring additional glycaemic control
Understanding the causes of high vitamin B12 can help doctors identify potential underlying health conditions
Why its popular: Visibility is the main drawyou can watch the entire process, which helps build confidence during those first few injections
This is what I tell my patients when they ask me which one is "better." The Short Answer Tirzepatide produces more weight loss on average
